These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 19671749)

  • 61. Rigid linkers for bioactive peptides.
    Vagner J; Handl HL; Monguchi Y; Jana U; Begay LJ; Mash EA; Hruby VJ; Gillies RJ
    Bioconjug Chem; 2006; 17(6):1545-50. PubMed ID: 17105235
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors.
    Mo XL; Tao YX
    Biochim Biophys Acta; 2013 Dec; 1832(12):1939-48. PubMed ID: 23791567
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Characterization of a putative alpha-MSH antagonist 153N-6 at melanocortin receptor subtypes by radioligand binding.
    Chhajlani V
    Peptides; 1996; 17(2):349-51. PubMed ID: 8801544
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analogs of alpha-melanocyte stimulating hormone with high agonist potency and selectivity at human melanocortin receptor 1b: the role of Trp(9) in molecular recognition.
    Bednarek MA; Macneil T; Tang R; Fong TM; Angeles Cabello M; Maroto M; Teran A
    Biopolymers; 2008 May; 89(5):401-8. PubMed ID: 17926329
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues.
    Labbé O; Desarnaud F; Eggerickx D; Vassart G; Parmentier M
    Biochemistry; 1994 Apr; 33(15):4543-9. PubMed ID: 8161509
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Insights into the Allosteric Mechanism of Setmelanotide (RM-493) as a Potent and First-in-Class Melanocortin-4 Receptor (MC4R) Agonist To Treat Rare Genetic Disorders of Obesity through an in Silico Approach.
    Falls BA; Zhang Y
    ACS Chem Neurosci; 2019 Mar; 10(3):1055-1065. PubMed ID: 30048591
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of a time-resolved fluorescence probe for evaluation of competitive binding to the cholecystokinin 2 receptor.
    Elshan NG; Jayasundera T; Weber CS; Lynch RM; Mash EA
    Bioorg Med Chem; 2015 Apr; 23(8):1841-8. PubMed ID: 25769518
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Micromolar concentrations of rimonabant directly inhibits delta opioid receptor specific ligand binding and agonist-induced G-protein activity.
    Zádor F; Kocsis D; Borsodi A; Benyhe S
    Neurochem Int; 2014 Feb; 67():14-22. PubMed ID: 24508403
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative in Vivo Investigation of Intrathecal and Intracerebroventricular Administration with Melanocortin Ligands MTII and AGRP into Mice.
    Adank DN; Lunzer MM; Lensing CJ; Wilber SL; Gancarz AM; Haskell-Luevano C
    ACS Chem Neurosci; 2018 Feb; 9(2):320-327. PubMed ID: 28968061
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro and in vivo evaluation of 111In-DTPAGlu-G-CCK8 for cholecystokinin-B receptor imaging.
    Aloj L; Caracò C; Panico M; Zannetti A; Del Vecchio S; Tesauro D; De Luca S; Arra C; Pedone C; Morelli G; Salvatore M
    J Nucl Med; 2004 Mar; 45(3):485-94. PubMed ID: 15001692
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Structure-activity relationships of bifunctional peptides based on overlapping pharmacophores at opioid and cholecystokinin receptors.
    Agnes RS; Lee YS; Davis P; Ma SW; Badghisi H; Porreca F; Lai J; Hruby VJ
    J Med Chem; 2006 May; 49(10):2868-75. PubMed ID: 16686530
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Development of a homogeneous high throughput fluorescence polarization assay for G protein-coupled receptor binding.
    Lee PH; Bevis DJ
    J Biomol Screen; 2000 Dec; 5(6):415-19. PubMed ID: 11598459
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Melanocortin-4 receptor activation inhibits c-Jun N-terminal kinase activity and promotes insulin signaling.
    Chai B; Li JY; Zhang W; Wang H; Mulholland MW
    Peptides; 2009 Jun; 30(6):1098-104. PubMed ID: 19463742
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development and characterisation of novel fentanyl-delta opioid receptor antagonist based bivalent ligands.
    Bird MF; Vardanyan RS; Hruby VJ; Calò G; Guerrini R; Salvadori S; Trapella C; McDonald J; Rowbotham DJ; Lambert DG
    Br J Anaesth; 2015 Apr; 114(4):646-56. PubMed ID: 25680364
    [TBL] [Abstract][Full Text] [Related]  

  • 75. De novo design, synthesis, and pharmacology of alpha-melanocyte stimulating hormone analogues derived from somatostatin by a hybrid approach.
    Han G; Haskell-Luevano C; Kendall L; Bonner G; Hadley ME; Cone RD; Hruby VJ
    J Med Chem; 2004 Mar; 47(6):1514-26. PubMed ID: 14998337
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Extensive structure-activity studies of lactam derivatives of MT-II and SHU-9119: their activity and selectivity at human melanocortin receptors 3, 4, and 5.
    Grieco P; Balse-Srinivasan P; Han G; Weinberg D; MacNeil T; Van der Ploeg LH; Hruby VJ
    J Pept Res; 2003 Nov; 62(5):199-206. PubMed ID: 14531843
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In Vitro Mouse and Human Serum Stability of a Heterobivalent Dual-Target Probe That Has Strong Affinity to Gastrin-Releasing Peptide and Neuropeptide Y1 Receptors on Tumor Cells.
    Ghosh A; Raju N; Tweedle M; Kumar K
    Cancer Biother Radiopharm; 2017 Feb; 32(1):24-32. PubMed ID: 28186846
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Novel pharmacological MC4R agonists can efficiently activate mutated MC4R from obese patient with impaired endogenous agonist response.
    Roubert P; Dubern B; Plas P; Lubrano-Berthelier C; Alihi R; Auger F; Deoliveira DB; Dong JZ; Basdevant A; Thurieau C; Clément K
    J Endocrinol; 2010 Nov; 207(2):177-83. PubMed ID: 20696697
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M; Behr TM
    Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Melanocortin 4 receptor ligands modulate energy homeostasis through urocortin 1 neurons of the centrally projecting Edinger-Westphal nucleus.
    Füredi N; Nagy Á; Mikó A; Berta G; Kozicz T; Pétervári E; Balaskó M; Gaszner B
    Neuropharmacology; 2017 May; 118():26-37. PubMed ID: 28267582
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.